Form 4: Oded Levy, Director at Cardio Diagnostics Holdings, Reports Stock Option Grant and Disposal
SEC Form 4 Filing
Director Oded Levy reports acquisition of stock options and disposal of derivative securities at Cardio Diagnostics Holdings.
Summary
- Oded Levy, a director at Cardio Diagnostics Holdings, filed a Form 4.
- The report details the acquisition of 18,686 stock options with an exercise price of $0.22 on September 30, 2024.
- The options are exercisable immediately and expire on September 30, 2034.
- Levy also reported disposing of 26,261 derivative securities.
- Following these transactions, Levy owns 26,261 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock option transactions, with neutral sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and provides limited insight into broader industry trends.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to potential dilution from the exercise of stock options.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of earliest transaction: Acquisition of stock options and disposal of derivative securities. |
| 09/30/2024 | Date the acquired stock options become exercisable. |
| 09/30/2034 | Expiration date of the acquired stock options. |
| 10/10/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.